CGAS and autoimmune disease: Focusing on the particular ubiquitin ligases and deubiquitinating enzymes implicated in the cGAS-STING pathway presents a promising approach for the creation of therapeutics for autoimmune diseases, cancer, and viral infections, highlighting the necessity of investigating these interactions for novel therapeutic targets.